Xu ZG - Search Results

1

[Selective neck dissection in the management of tongue squamous cell carcinoma with clinically negative nodes].

Wang XL, Xu ZG, Tang PZ, Zhang B. Wang XL, et al. Among authors: xu zg. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2005 May;40(5):376-9. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2005. PMID: 16229184 Chinese.

2

[Reconstruction of defect after resection of hypopharyngeal and cervical esophageal cancer by multiple tissue flaps].

Wu Y, Li D, Li Z, Liu W, Wang X, Xu Z. Wu Y, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Sep;50(9):760-4. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015. PMID: 26696350 Chinese.

3

Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study.

Cao S, Zhou Z, Chen C, Li W, Liu J, Xu J, Zhao C, Yuan Y, Xu Z, Wu H, Ji G, Xu X, Wang K. Cao S, et al. World J Surg Oncol. 2024 Sep 7;22(1):240. doi: 10.1186/s12957-024-03523-1. World J Surg Oncol. 2024. PMID: 39244533 Free PMC article.

4

Design, Synthesis, and Biological Evaluation of Thieno[3,2-d]pyrimidine Derivatives as the First Bifunctional PI3Kδ Isoform Selective/Bromodomain and Extra-Terminal Inhibitors.

Ran K, Huang JH, Li Y, Zhang Y, Hu H, Wang Z, Tang DY, Li HY, Xu ZG, Chen ZZ. Ran K, et al. Among authors: xu zg. J Med Chem. 2025 Jan 24. doi: 10.1021/acs.jmedchem.4c02478. Online ahead of print. J Med Chem. 2025. PMID: 39853339

5

Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma.

Wu HY, Cao SY, Xu ZG, Wang T, Ji GW, Wang K. Wu HY, et al. Among authors: xu zg. BMC Cancer. 2025 Jan 23;25(1):131. doi: 10.1186/s12885-025-13433-4. BMC Cancer. 2025. PMID: 39849389

6

Circulating tumor cell dynamic detecting to optimize neoadjuvant chemotherapy combined with liver transplantation in perihilar cholangiocarcinoma.

Liang WJ, Liang C, Xu ZG, Ye SJ, Zhong ZB, Ye QF. Liang WJ, et al. Among authors: xu zg. Hepatobiliary Pancreat Dis Int. 2024 Dec 16:S1499-3872(24)00164-4. doi: 10.1016/j.hbpd.2024.12.002. Online ahead of print. Hepatobiliary Pancreat Dis Int. 2024. PMID: 39753428 No abstract available.

7

HFIP-driven Schmidt-type reaction enables chromone-3-carbonitriles and its applications.

Xu J, Lei J, Zhang LX, Yu S, Zhou CH, Xu ZG, Du HW, Chen ZZ. Xu J, et al. Among authors: xu zg. Mol Divers. 2024 Nov 23. doi: 10.1007/s11030-024-11027-z. Online ahead of print. Mol Divers. 2024. PMID: 39579260

8

Discovery and optimization of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives as potent BET inhibitors for cancer therapy.

Ran K, Li Y, Zhang YM, Tang DY, Chen ZZ, Xu ZG, Zhang L, Wang BC, Huang JH. Ran K, et al. Among authors: xu zg. Bioorg Chem. 2024 Dec;153:107929. doi: 10.1016/j.bioorg.2024.107929. Epub 2024 Nov 2. Bioorg Chem. 2024. PMID: 39509789

9

Copper-Catalyzed Radical Sulfonylation: Divergent Construction of C(sp³)-Sulfonyl Bonds with Sulfonylhydrazones.

Yu S, Lei J, Xu J, Li X, Zhang B, Xu ZG, Lv ML, Tang DY, Chen ZZ. Yu S, et al. Among authors: xu zg. J Org Chem. 2024 Nov 15;89(22):16340-16350. doi: 10.1021/acs.joc.4c00784. Epub 2024 Nov 6. J Org Chem. 2024. PMID: 39504540

10

Glymphatic System Dysfunction in Congenital Sensorineural Hearing Loss: A DTI-ALPS Study.

Sha L, Xu ZG, Chen YC. Sha L, et al. Among authors: xu zg. Curr Med Imaging. 2024;20:e15734056305276. doi: 10.2174/0115734056305276240730113140. Curr Med Imaging. 2024. PMID: 39108006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters